PHARMACOLOGY OF ENANTIOMERS AND (-) P-OH METABOLITE OF INDACRINONE

被引：30

作者：

VLASSES, PH

IRVIN, JD

HUBER, PB

LEE, RB

FERGUSON, RK

SCHROGIE, JJ

ZACCHEI, AG

DAVIES, RO

ABRAMS, WB

机构：

[1] MERCK SHARP & DOHME,RES LABS,DEPT CLIN PHARMACOL,W POINT,PA 19486

[2] MERCK SHARP & DOHME,RES LABS,DEPT DRUG METAB,W POINT,PA 19486

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1981年 / 29卷 / 06期

关键词：

D O I：

10.1038/clpt.1981.114

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：798 / 807

页数：10

共 16 条

[1] (ACYLARYLOXY)ACETIC ACID DIURETICS .2. (2-ALKYL-2-ARYL-1-OXO-5-INDANYLOXY)ACETIC ACIDS [J].

DESOLMS, SJ ;

WOLTERSDORF, OW ;

CRAGOE, EJ ;

WATSON, LS ;

FANELLI, GM .

JOURNAL OF MEDICINAL CHEMISTRY, 1978, 21 (05) :437-443

[2]

DOBRINSKA MR, 1980, AUG P WORLD C CLIN P

[3]

DOBRINSKA MR, 1979, APHA ACAD PHARM SCI, V9, P108

[4] URICOSURIC RESPONSE TO INCREASING DOSES OF THE INDANONE DIURETIC MK-196 IN HEALTHY-VOLUNTEERS [J].

EMMERSON, BT ;

THOMPSON, L ;

MITCHELL, K .

NEPHRON, 1979, 23 :38-40

[5]

FANELLI GM, 1977, J PHARMACOL EXP THER, V200, P402

[6]

FANELLI GM, 1977, J PHARMACOL EXP THER, V200, P413

[7] COMPARISON OF ORAL INDACRINONE WITH FUROSEMIDE [J].

IRVIN, JD ;

VLASSES, PH ;

HUBER, PB ;

FERGUSON, RK ;

SCHROGIE, JJ ;

DAVIES, RO .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (03) :376-383

[8]

LACORTE W, 1979, CLIN PHARMACOL THER, V25, P233

[9] ENHANCEMENT OF URICOSURIC PROPERTIES OF INDACRINONE BY MANIPULATION OF THE ENANTIOMER RATIO [J].

TOBERT, JA ;

CIRILLO, VJ ;

HITZENBERGER, G ;

JAMES, I ;

PRYOR, J ;

COOK, T ;

BUNTINX, A ;

HOLMES, IB ;

LUTTERBECK, PM .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (03) :344-350

[10]

VEDIN JA, 1979, BR J CLIN PHARM, V8, P261

← 1 2 →